Skip to content
sellModerate cluster of 410b5-1 plan

Matthew Rabinowitz sold $35M of NTRA

EXECUTIVE CHAIRMAN at Natera, Inc.. 102,000 shares at an average of $341.15, traded Sep 14, 2026, filed Sep 16, 2026.

Warning score
40
Value
$35M
102,000 shares
Holdings after
0
-5% from before
From 52-week low
+113%
low $160.21, close $341.79
From 52-week high
0%
high $341.79, as of Sep 14, 2026

Score components

  • Role
    Chair
    +20
  • Trade size
    $34.8M at market
    +25
  • Share of holdings sold
    Sold 4.6% of holdings
    0
  • Cluster
    4 insiders selling within 14 days
    +15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

NTRAOct 9, 2026 · close 400.71
Since filing Sep 16, 2026: +16.0%SPY +3.5% · excess +12.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001646382-26-000021, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-1,537$328.09$504k2,223,85726 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-6,015$329.12$2.0M2,217,84226 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-6,206$330.05$2.0M2,211,63626 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-3,494$330.98$1.2M2,208,14226 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-1,000$332.02$332k2,207,14226 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-2,246$333.07$748k2,204,89626 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-2,818$334.24$942k2,202,07826 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-3,754$335.18$1.3M2,198,32426 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-8,459$336.27$2.8M2,189,86526 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-2,207$337.17$744k2,187,65826 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-1,400$338.30$474k2,186,25826 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-2,100$339.37$713k2,184,15826 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-2,000$340.31$681k2,182,15826 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-2,700$341.35$922k2,179,45826 d ago
Sep 14, 2026SOpen-market sale
Common Stock10b5-1
-4,064$342.51$1.4M2,175,39426 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-1,481$339.24$502k2,173,91326 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-2,549$340.25$867k2,171,36426 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-1,813$341.41$619k2,169,55126 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-1,956$342.18$669k2,167,59526 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-2,240$343.56$770k2,165,35526 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-5,839$344.49$2.0M2,159,51626 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-2,700$345.38$933k2,156,81626 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-1,122$346.68$389k2,155,69426 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-2,700$347.81$939k2,152,99426 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-8,094$348.65$2.8M2,144,90026 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-4,206$349.51$1.5M2,140,69426 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-14,500$350.81$5.1M2,126,19426 d ago
Sep 15, 2026SOpen-market sale
Common Stock10b5-1
-800$351.25$281k2,125,39426 d ago
Sep 15, 2026SOpen-market sale
Common Stockindirect: By spouse10b5-1
-2,000$350.01$700k026 d ago

Related signals

Other insiders at Natera, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
38Weak
NTRAsell 310b5-1
Natera, Inc.
Steven Leonard Chapman
CEO AND PRESIDENT
$526k
1,273 shares
-1%
40Moderate
NTRAsell 310b5-1
Natera, Inc.
Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS
$1.2M
3,000 shares
-3%
55Moderate
NTRAsell 410b5-1
Natera, Inc.
Jonathan Sheena
director, other
$7.0M
18,064 shares
-100%
35Weak
NTRAsell 410b5-1
Natera, Inc.
Jonathan Sheena
director, other
$3.2M
9,150 shares
-4%
40Moderate
NTRAsell 410b5-1
Natera, Inc.
Matthew Rabinowitz
EXECUTIVE CHAIRMAN
$16M
50,000 shares
-2%
39Weak
NTRAsell 410b5-1
Natera, Inc.
Steven Leonard Chapman
CEO AND PRESIDENT
$545k
1,698 shares
-2%
45Moderate
NTRAsell 410b5-1
Natera, Inc.
Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS
$5.9M
18,160 shares
-14%
29Weak
NTRAsell10b5-1
Natera, Inc.
Steven Leonard Chapman
CEO AND PRESIDENT
$960k
6,111 shares
-3%
45Moderate
NTRAsell 310b5-1
Natera, Inc.
Steven Leonard Chapman
CEO AND PRESIDENT
$1.0M
6,980 shares
-4%
39Weak
NTRAsell 310b5-1
Natera, Inc.
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER
$777k
5,063 shares
-7%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Matthew Rabinowitz sold $35M of NTRA | InsiderTell